trial

Cognitive Remediation Therapy and Schizophrenia

NCTId NCT01078129
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 77 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2008-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
77 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2006-01
Primary completion
2008-03
Eligibility
ALL · 18 Years · 40 Years

Interventions & indications

Drugs
Cognitive Remediation Therapynon-CRT

Sponsors

Hôpital le VinatierLead Sponsor
University Hospital, GrenobleCollaborator
University Hospital, Clermont-FerrandCollaborator

Investigators

1
Thierry d'amato, MD, PhDPrincipal Investigator

Sites

1 total
Bron, France

Facts & assertions

4 sourced
Enrollment
77
Phase
NA
Primary Completion Date
2008-03
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive Remediation Therapy
drug
non-CRT
drug
lead_sponsor
Hôpital le Vinatier
company
collaborator
University Hospital, Grenoble
company
University Hospital, Clermont-Ferrand
company
indication
Schizophrenia
indication
Schizophrenia
indication
Cognition Disorders
indication
investigator
Thierry d'amato, MD, PhD
person